Related Experiment Videos
Usefulness of B-type natriuretic peptide (BNP) as a screen for left ventricular abnormalities in diabetes mellitus
1Service de Cardiologie, Hôpital Lariboisière, Paris, France. stephane.cosson1@libertysurf.fr
Insights
B-type natriuretic peptide (BNP) testing can help rule out left ventricular dysfunction in diabetic patients. Further research is needed to determine if BNP can aid in managing diabetic patients with cardiovascular disease.
Area of Science:
- Cardiology
- Endocrinology
- Biomarkers
Background:
- Cardiovascular disease (CVD) is a primary cause of death in diabetic individuals.
- Diabetes elevates the risk of left ventricular hypertrophy, dysfunction, and coronary artery disease.
- B-type natriuretic peptide (BNP) is a hormone released by ventricles under stress.
Purpose of the Study:
- To evaluate the role of BNP testing in identifying left ventricular dysfunction in diabetic patients.
- To assess the utility of BNP as a screening tool for heart failure in this high-risk population.
Main Methods:
- Review of numerous studies on BNP levels in relation to left ventricular dysfunction and coronary artery disease.
- Analysis of BNP testing's impact on diagnosing heart failure in non-specialist settings.
Main Results:
- BNP levels are frequently elevated in patients with left ventricular dysfunction, hypertrophy, and coronary artery disease.
- BNP testing improves heart failure diagnosis accuracy for non-specialist physicians.
- BNP serves as an effective 'rule out' test for left ventricular dysfunction in high-risk patients, including those with diabetes.
Conclusions:
- BNP testing is valuable for screening and diagnosing left ventricular dysfunction in diabetic patients.
- Further studies are required to confirm BNP's role in the future management of diabetic patients.
- BNP aids in ruling out cardiac issues in diabetic individuals at risk for left ventricular dysfunction.
Abstract:
Cardiovascular disease is the leading cause of morbidity and mortality in diabetic subjects. Diabetes, independently of the mechanism, is associated with an increased risk of left ventricular hypertrophy, left ventricular dysfunction and coronary artery disease. B-type natriuretic peptide (BNP) is a cardiac neurohormone predominantly released from the cardiac ventricles in response to left ventricular volume expansion and pressure overload. Numerous studies have shown that BNP levels are elevated in asymptomatic or symptomatic left ventricular dysfunction, hypertrophy and coronary artery disease. BNP testing plays an important role in the screening and diagnosis of left ventricular dysfunction by improving the performance of non-specialist physicians in diagnosing heart failure. In clinical practice, BNP testing is best used as a 'rule out' test targeted to patients at high risk for left-ventricular dysfunction, such as those with diabetes. Studies are needed to establish if this promising biological tool, in the next future, would assist the management of diabetic patients.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Diabetic Nephropathy
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...